Imamura General Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia2 trials
• Acute myeloid leukaemia1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Ulcerative colitis1 trial

Phase

• Phase 23 trials
• Phase 1/21 trial
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Daiichi Sankyo Co., Ltd.1 trial
• Kyowa Kirin Co., Ltd.1 trial
• Otsuka Medical Devices Co., Ltd. Japan1 trial

Running trials

• Recruiting

  A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

  NCT07623616· Phase 2· Kyowa Kirin Co., Ltd.· Source

  Contact: Kyowa Kirin, Inc.

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

  NCT07321873· Phase 2· Janssen Research & Development, LLC· Source

• Recruiting

  A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma

  NCT07075328· Phase 1/2· Otsuka Medical Devices Co., Ltd. Japan· Source

  Contact: Kentaro Ishinabe

• Active, not recruiting

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting

Closed trials

• Completed

  Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma

  NCT04102150· Phase 2· Daiichi Sankyo Co., Ltd.· Source